Mesoblast (ASX:MSB) received notice that JPMorgan Chase and its affiliates became a substantial holder of the company on Feb. 4, according to a Monday filing with the Australian bourse.
JPMorgan Chase now owns 65.2 million shares in the company, representing 5.05% voting power, the filing said.
Shares of the company rose 6% in recent Monday trade.